JP2010523644A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523644A5
JP2010523644A5 JP2010502609A JP2010502609A JP2010523644A5 JP 2010523644 A5 JP2010523644 A5 JP 2010523644A5 JP 2010502609 A JP2010502609 A JP 2010502609A JP 2010502609 A JP2010502609 A JP 2010502609A JP 2010523644 A5 JP2010523644 A5 JP 2010523644A5
Authority
JP
Japan
Prior art keywords
amino
dione
trifluoromethyl
methyl
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010502609A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523644A (ja
JP5635396B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2008/003036 external-priority patent/WO2009031040A2/en
Publication of JP2010523644A publication Critical patent/JP2010523644A/ja
Publication of JP2010523644A5 publication Critical patent/JP2010523644A5/ja
Application granted granted Critical
Publication of JP5635396B2 publication Critical patent/JP5635396B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010502609A 2007-04-11 2008-04-11 抗がん活性を有する化合物 Active JP5635396B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91125807P 2007-04-11 2007-04-11
US60/911,258 2007-04-11
PCT/IB2008/003036 WO2009031040A2 (en) 2007-04-11 2008-04-11 Compounds with anti-cancer activity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013176324A Division JP2014012706A (ja) 2007-04-11 2013-08-28 抗がん活性を有する化合物

Publications (3)

Publication Number Publication Date
JP2010523644A JP2010523644A (ja) 2010-07-15
JP2010523644A5 true JP2010523644A5 (https=) 2011-05-12
JP5635396B2 JP5635396B2 (ja) 2014-12-03

Family

ID=39939984

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010502609A Active JP5635396B2 (ja) 2007-04-11 2008-04-11 抗がん活性を有する化合物
JP2013176324A Withdrawn JP2014012706A (ja) 2007-04-11 2013-08-28 抗がん活性を有する化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013176324A Withdrawn JP2014012706A (ja) 2007-04-11 2013-08-28 抗がん活性を有する化合物

Country Status (17)

Country Link
US (2) US8084454B2 (https=)
EP (4) EP3088397B1 (https=)
JP (2) JP5635396B2 (https=)
KR (1) KR101475311B1 (https=)
CN (2) CN105175394B (https=)
AU (1) AU2008294410B2 (https=)
BR (2) BRPI0810911B1 (https=)
CA (4) CA3188320A1 (https=)
DK (2) DK2152692T3 (https=)
ES (3) ES2927954T3 (https=)
HU (2) HUE029370T2 (https=)
IL (4) IL289165B2 (https=)
MX (3) MX391154B (https=)
NZ (1) NZ580237A (https=)
RU (1) RU2482111C2 (https=)
WO (1) WO2009031040A2 (https=)
ZA (1) ZA200906960B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3088397B1 (en) * 2007-04-11 2019-04-10 Canbas Co. Ltd. Compounds that abrogate the cell cycle g2 checkpoint for use in the treatment of cancer
EP2304436A1 (en) 2008-07-10 2011-04-06 Nodality, Inc. Methods for diagnosis, prognosis and treatment
EP2393488B1 (en) * 2009-02-06 2019-06-19 University Of Southern California Therapeutic compositions comprising monoterpenes
US20100215644A1 (en) * 2009-02-25 2010-08-26 Nodality, Inc. A Delaware Corporation Analysis of nodes in cellular pathways
EP2542082B8 (en) 2010-03-03 2020-06-17 Neonc Technologies Inc. PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-perillyl alcohol
US20160038600A1 (en) 2012-08-03 2016-02-11 Neonc Technologies Inc. Pharmaceutical compositions comprising poh derivatives
DK3685835T3 (da) 2010-08-27 2025-07-21 Univ Southern California Farmaceutiske sammensætninger, der omfatter derivater af perillylalkohol
ES3056006T3 (en) 2010-12-17 2026-02-17 Univ Southern California Methods and devices for using isoperillyl alcohol
WO2013020024A2 (en) * 2011-08-03 2013-02-07 Karyopharm Therapeutics, Inc. Maleimide compounds and methods of treatment
US9814693B2 (en) 2012-05-09 2017-11-14 Delmar Pharmaceuticals, Inc. Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies
IN2014MN02512A (https=) 2012-06-14 2015-07-17 Daiichi Sankyo Co Ltd
WO2014118186A1 (en) * 2013-01-30 2014-08-07 Bayer Pharma Aktiengesellschaft Amino-substituted isothiazoles
US9540462B2 (en) 2014-12-05 2017-01-10 Massachusetts Institute Of Technology Catechol-rich polymers from N-substituted maleimides
FI3250550T3 (fi) 2015-01-26 2023-07-17 Ottawa Hospital Res Inst Koostumuksia ja menetelmiä virusherkistymiseen
JP6674957B2 (ja) 2015-02-12 2020-04-01 ネオンク テクノロジーズ インク. ペリリルアルコール誘導体を含む医薬組成物
CN109071444A (zh) 2016-03-16 2018-12-21 拜耳作物科学股份公司 作为农药和植物保护剂的n-(氰苄基)-6-(环丙基-羰基氨基)-4-(苯基)-吡啶-2-羧酰胺衍生物及相关化合物
USD801721S1 (en) 2016-03-31 2017-11-07 Patricia Grayson Briden Spooled item holding device
USD915100S1 (en) 2016-03-31 2021-04-06 Ocean 22, Llc Spooled item holding device
TW201811766A (zh) 2016-08-29 2018-04-01 瑞士商諾華公司 N-(吡啶-2-基)吡啶-磺醯胺衍生物及其用於疾病治療之用途
JP2021512165A (ja) 2018-01-29 2021-05-13 コグノス・セラピューティクス・インコーポレイテッド ボルテゾミブの腫瘍内送達
MX2020007994A (es) 2018-02-02 2020-09-09 Boehringer Ingelheim Int Derivados de triazolopirimidina para usar como inhibidores de ghrelin o-aciltransferasa (goat).
WO2019149657A1 (en) 2018-02-02 2019-08-08 Boehringer Ingelheim International Gmbh Benzyl-, (pyridin-3-yl)methyl- or (pyridin-4-yl)methyl-substituted oxadiazolopyridine derivatives as ghrelin o-acyl transferase (goat) inhibitors
CN111936125B (zh) 2018-02-08 2025-03-04 南加州大学 穿透血脑屏障的方法
DK4153599T3 (da) 2020-05-22 2024-06-17 Boehringer Ingelheim Int Fremgangsmåde til at fremstille alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridin-carboxylat
ES2991340T3 (es) 2020-05-22 2024-12-03 Boehringer Ingelheim Int Procedimiento continuo de fabricación de 7-amino-5-metil-[1,2,5]oxadiazolo[3,4-b]piridín-carboxilato de alquilo
EP4415700A4 (en) * 2021-10-15 2025-12-24 Univ Missouri P1B TYPE ATPASES INHIBITORS
CN114425054A (zh) * 2022-01-20 2022-05-03 中国人民解放军军事科学院军事医学研究院 一种蛋白酶体抑制剂Bortezomib在抗辐射损伤中的用途
CN120247782B (zh) * 2025-06-04 2025-08-19 北京颖泰嘉和生物科技股份有限公司 氟吡菌酰胺类化合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5564557A (en) * 1978-11-08 1980-05-15 Mitsui Toatsu Chem Inc Diphenyl ether compound and herbicide containing the same
IL81307A0 (en) * 1986-01-23 1987-08-31 Union Carbide Agricult Method for reducing moisture loss from plants and increasing crop yield utilizing nitrogen containing heterocyclic compounds and some novel polysubstituted pyridine derivatives
US5635966A (en) * 1994-01-11 1997-06-03 Hewlett-Packard Company Edge feed ink delivery thermal inkjet printhead structure and method of fabrication
JPH07224032A (ja) 1994-02-09 1995-08-22 Mitsui Petrochem Ind Ltd N−アリールオキシフタルイミド誘導体、その製造方 法及びそれを有効成分として含有する除草剤
JPH07244032A (ja) * 1994-03-01 1995-09-19 Ishikawajima Harima Heavy Ind Co Ltd 溶接部検査装置
CA2230896A1 (en) * 1995-09-01 1997-03-13 Signal Pharmaceuticals, Inc. Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions
US5935966A (en) * 1995-09-01 1999-08-10 Signal Pharmaceuticals, Inc. Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions
CA2245029A1 (en) * 1998-03-13 1999-09-13 University Of British Columbia Granulatimide compounds as g2 checkpoint inhibitors
US6205557B1 (en) 1998-06-09 2001-03-20 At&T Corp. Redundant call processing
AU2093400A (en) * 1998-11-24 2000-06-13 Basf Aktiengesellschaft Fungicides containing pyrrolidones as their active agents
JP4610828B2 (ja) 1999-09-22 2011-01-12 株式会社 キャンバス G2期細胞周期停止の阻害、およびdna損傷剤に対する細胞感作のための組成物および方法
EP1257172B1 (de) 2000-02-26 2004-10-13 Basf Aktiengesellschaft Fungizide mittel enthaltend als wirkstoffe pyrrolidone und deren verwendung bei der behandlung von pflanzen
JP2002318434A (ja) * 2001-04-23 2002-10-31 Konica Corp ハロゲン化銀写真感光材料、処理方法、および画像形成方法
FR2826653B1 (fr) * 2001-06-29 2005-10-14 Servier Lab Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2003104181A2 (en) * 2002-06-06 2003-12-18 Canbas Co. Ltd. Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments
WO2005024755A2 (en) * 2002-12-31 2005-03-17 Deciphera Pharmaceuticals, Llc. Medicaments for the treatment of neurodegenerative disorders or diabetes
US7572816B2 (en) * 2003-08-01 2009-08-11 Auspex Pharmaceuticals, Inc. Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
US7932281B2 (en) * 2004-03-10 2011-04-26 Kureha Corporation Amine-based compound and use thereof
EP1730128A1 (en) * 2004-03-31 2006-12-13 Exelixis, Inc. Anaplastic lymphoma kinase modulators and methods of use
AU2006212951A1 (en) * 2005-02-08 2006-08-17 Merck & Co., Inc. Inhibitors of checkpoint kinases
JP4976394B2 (ja) * 2005-08-17 2012-07-18 シェーリング コーポレイション 新規な高親和性のキノリンベースのキナーゼリガンド
CA2627910A1 (en) * 2005-11-01 2007-05-10 Janssen Pharmaceutica N.V. Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
WO2007114338A1 (ja) * 2006-03-31 2007-10-11 Takeda Pharmaceutical Company Limited 酸分泌抑制薬
WO2008110891A2 (en) 2007-03-09 2008-09-18 Orchid Research Laboratories Limited, New heterocyclic compounds
EP3088397B1 (en) 2007-04-11 2019-04-10 Canbas Co. Ltd. Compounds that abrogate the cell cycle g2 checkpoint for use in the treatment of cancer

Similar Documents

Publication Publication Date Title
JP2010523644A5 (https=)
RU2482111C2 (ru) Соединения, обладающие противораковой активностью
RU2451675C2 (ru) ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА В КАЧЕСТВЕ АГОНИСТОВ β2-АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
CN1942186B (zh) 吡咯烷化合物
JP2013515038A5 (https=)
JP2013517283A5 (https=)
JP2009524589A5 (ja) 置換されたイソキノリン−1,3(2h,4h)−ジオン、1−チオキソ−1,4−ジヒドロ−2h−イソキノリン−3−オン、および1,4−ジヒドロ−3(2h)−イソキノロン、ならびにキナーゼインヒビターとしてのそれらの使用
JP2011520941A5 (https=)
JP2013503901A5 (https=)
HRP20110939T1 (hr) Supstituirani benzimidazoli kao inhibitori kinaze
JP2012520867A5 (https=)
KR20010006487A (ko) 조합된 5ht1a, 5ht1b 및 5ht1d 수용체 길항 활성을 갖는 인돌 유도체
RU2017139727A (ru) Гетероциклические ингибиторы erk1 и erk2 и их применение для лечения злокачественного новообразования
JP2009536620A5 (https=)
JP2009541461A5 (https=)
JP2005538955A5 (https=)
JP2016506964A5 (ja) ナトリウムチャネルの調節剤としてのキノリンおよびキノキサリンアミド
JP2015500212A5 (https=)
RU2010110640A (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
JPWO2023064857A5 (https=)
CA2551508A1 (en) Novel quinoline derivatives
JP2010513304A5 (https=)
JP2015523383A5 (https=)
WO2006076575B1 (en) Substituted biaryl compounds as factor xia inhibitors
JP2010529991A5 (https=)